Defending the NHS from cyber-attacks in 2022
The study of genes is vital for accurate patient care
THE BRIEF
“ This is not a problem that is going to be solved individually . The healthcare industry must work together ”
BY THE NUMBERS
Adverse drug reactions were ranked as the fourth leading cause of death in the U . S . by the FDA in 2018 .
Tarquin Scadding-Hunt CEO , mdgroup �
READ MORE
“ With our legacy of products , it just was a natural progression into the healthcare industry ”
Paul Burke Senior Director , American OEM ( North ) at Lenovo �
READ MORE
“ Since the WannaCry global ransomware attack , there has been a widespread view that the NHS is vulnerable to other serious attacks ”
Sean Tickle Head of CyberGuard Technologies Limited �
READ MORE
Defending the NHS from cyber-attacks in 2022
Behind the turmoil of the pandemic , upholding cyber security remains a priority for the healthcare industry and 2022 is a battlefield .
The study of genes is vital for accurate patient care
Wolters Kluwer uses pharmacogenomics ( how differences in genes influence drug responses ) to study the cause of adverse drug reactions – which can be deadly .
10 February 2022